文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

乳酸水平对心脏与非心脏手术后危重患者预后的影响:549例分析

[Effect of lactic acid levels on the prognosis of critically ill patients after cardiac and non-cardiac surgery: an analysis of 549 cases].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2018-01-01
一句话结论非心脏手术后高乳酸血症及乳酸变异性与ICU死亡风险相关,术后24小时内最高乳酸或可用于预后评估。

该回顾性研究纳入2014年9月至2016年9月郑州大学第一附属医院ICU收治的549例成人术后患者(心脏手术268例,非心脏手术281例),按平均乳酸浓度分为正常乳酸组(0-2 mmol/L)、相对高乳酸组(2-4 mmol/L)和绝对高乳酸组(>4 mmol/L),并分析乳酸变异性与ICU死亡风险的关系。结果显示,绝对高乳酸组(>4 mmol/L)非心脏手术患者ICU死亡率明显高于心脏手术患者[69.2%(18/26)vs. 43.6%(24/55),OR=0.344,P=0.036]。非心脏手术组乳酸变异性与ICU死亡风险呈线性关系,最高变异性组(>1.44 mmol×L-1×d-1)OR=22.66(P<0.01)。24小时内最高乳酸的ROC曲线下面积在心脏手术组和非心脏手术组分别为0.877和0.875,均大于首次乳酸。作者认为非心脏手术后应更积极控制高乳酸血症和乳酸变异性,24小时内最高乳酸可能是评估术后患者预后的指标之一。

要点

  • 非心脏手术后绝对高乳酸(>4 mmol/L)患者ICU死亡率69.2%(18/26),明显高于心脏手术患者的43.6%(24/55)(OR=0.344,P=0.036)。
  • 非心脏手术组乳酸变异性>1.44 mmol×L-1×d-1时ICU死亡风险OR=22.66(P<0.01),0.85-1.44时OR=4.86(P=0.04)。
  • 心脏手术组仅乳酸变异性最高组(>2.43 mmol×L-1×d-1)死亡风险有差异(OR=12.14,P<0.01)。
  • 24小时内最高乳酸预测ICU死亡的AUC在心脏手术组为0.877(cut-off 5.35 mmol/L),非心脏手术组为0.875(cut-off 5.65 mmol/L),均优于首次乳酸。
  • 作者认为非心脏手术后应更积极控制高乳酸血症和乳酸变异性,24小时内最高乳酸可能是评估术后患者预后的指标之一。

适用人群与场景

  • 心脏手术和非心脏手术后立即转入ICU的术后患者,年龄至少18岁,ICU停留时间至少1天,收治于郑州大学第一附属医院ICU(2014年9月至2016年9月)。

诊断标准与关键阈值

  • 按平均乳酸浓度分组:正常乳酸组(0-2 mmol/L)、相对高乳酸组(2-4 mmol/L)、绝对高乳酸组(>4 mmol/L)。
  • 按乳酸变异性四分位数分组:非心脏手术组<0.50、0.50-0.85、0.85-1.44、>1.44 mmol×L-1×d-1;心脏手术组<0.55、0.55-1.25、1.25-2.43、>2.43 mmol×L-1×d-1。
  • 24小时内最高乳酸预测ICU死亡的cut-off值:心脏手术组5.35 mmol/L,非心脏手术组5.65 mmol/L。

研究设计与关键结果

  • 回顾性研究,纳入549例成人术后转入ICU的患者(心脏手术268例,非心脏手术281例),基线资料均衡。
  • 正常乳酸组(0-2 mmol/L)心脏手术与非心脏手术的ICU死亡率无显著差异[7.9%(14/177)vs. 6.5%(14/217),OR=1.245,P=0.694]。
  • 相对高乳酸组(2-4 mmol/L)两组ICU死亡率无显著差异[33.3%(12/36)vs. 23.7%(9/38),OR=1.611,P=0.442]。
  • 绝对高乳酸组(>4 mmol/L)非心脏手术组ICU死亡率明显高于心脏手术组[69.2%(18/26)vs. 43.6%(24/55),OR=0.344,P=0.036]。
  • 非心脏手术组乳酸变异性与ICU死亡风险呈线性关系:<0.50为参照,0.50-0.85(OR=1.17,P=0.87),0.85-1.44(OR=4.86,P=0.04),>1.44(OR=22.66,P<0.01)。
  • 心脏手术组乳酸变异性与死亡风险:<0.55为参照,0.55-1.25(OR=0.61,P=0.61),1.25-2.43(OR=3.46,P=0.10),>2.43(OR=12.14,P<0.01),仅最高变异性组有差异。
  • 24小时内最高乳酸预测ICU死亡的AUC在心脏手术组为0.877(cut-off 5.35 mmol/L,敏感度81.4%,特异度93.8%),非心脏手术组为0.875(cut-off 5.65 mmol/L,敏感度67.9%,特异度96.1%),均大于首次乳酸。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为非心脏手术后应更积极控制高乳酸血症和乳酸变异性。
  • 作者认为24小时内最高乳酸可能是评估术后患者预后的指标之一。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To compare the impact of mean lactate concentration and lactate variability on postoperative outcome after cardiac surgery and non-cardiac surgery in critical patients, and to explore the prognostic value of the first lactate and the highest lactate during the first 24 hours in intensive care unit (ICU).

METHODS: A retrospective study was conducted. The postoperative patients of cardiac surgery and non-cardiac surgery who were transferred to ICU immediately, and who were at least 18 years old and whose ICU lengths of stay were at least 1 day, and who were admitted to ICU of the First Affiliated Hospital of Zhengzhou University from September 2014 to September 2016 were enrolled. According to the mean lactate concentration, the patients were divided into normal lactate group (0-2 mmol/L), relatively high lactate group (2-4 mmol/L), and absolute high lactate group (> 4 mmol/L), and the relationship between the mean lactate concentration and the prognosis of patients was analyzed. According to the degree of lactate variability, the patients were divided into four groups, and multivariate regression models were used to assess the risk of death in three different lactate variability groups. The value of the first lactate value and the highest lactate value during the first 24 hours in ICU were evaluated to predict the prognosis by the receiver operating characteristic (ROC) curve.

RESULTS: 268 postoperative patients of cardiac surgery and 281 cases of non-cardiac surgery were selected, and the characteristic of the baseline data in the two groups was balanced. (1) Mean lactate concentration and mortality in ICU: in the normal lactate group (0-2 mmol/L), there was no significant difference in mortality between the post-cardiac operative group and post-non-cardiac operative group [7.9% (14/177) vs. 6.5% (14/217), odds ratio (OR) = 1.245, P = 0.694]. In the relatively high lactate group (2-4 mmol/L), there was no significant difference between the two groups, either [33.3% (12/36) vs. 23.7% (9/38), OR = 1.611, P = 0.442]. In the absolute high lactate group (> 4 mmol/L), ICU mortality in post-non-cardiac operative group was obviously higher than that of post-cardiac operative group [69.2% (18/26) vs. 43.6% (24/55), OR = 0.344, P = 0.036]. (2) The ranges of lactate variability per quartile (mmol×L-1×d-1) and ICU mortality risk: there was a linear relationship between lactate variability and ICU mortality in post-non-cardiac operative group, < 0.50 (reference), 0.50-0.85 (OR = 1.17, P = 0.87), 0.85-1.44 (OR = 4.86, P = 0.04), > 1.44 (OR = 22.66, P < 0.01) , and there was a significant difference between the two groups in the high degree of variability (0.85-1.44 and > 1.44). The risk of death after cardiac surgery tended to increase, < 0.55 (reference), 0.55-1.25 (OR = 0.61, P = 0.61), 1.25-2.43 (OR = 3.46, P = 0.10), > 2.43 (OR = 12.14, P < 0.01), and the risk of death only showed difference in the highest degree of variation (> 2.43). (3) ROC curve showed that the area under ROC curves (AUC) of the highest lactate in 24 hours were larger than that of the first lactate in both groups, with higher sensitivity and specificity. In the post-cardiac operative group and post-non-cardiac operative group, the AUC of the highest lactate in the first 24 hours were 0.877 and 0.875, the cut-off values were 5.35 mmol/L and 5.65 mmol/L, the sensitivity were 81.4% and 67.9%, and the specificity were 93.8% and 96.1%, respectively.

CONCLUSIONS: Patients with post-non-cardiac operation should be more active in controlling hyperlactatemia and lactate variability. The highest lactate in the first 24 hours maybe one of the indicator for the assessment of the prognosis of the postoperative patients.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Sun R, Chao K, Yang H, et al. [Effect of lactic acid levels on the prognosis of critically ill patients after cardiac and non-cardiac surgery: an analysis of 549 cases]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 29402360. doi:10.3760/cma.j.issn.2095-4352.2018.02.006

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。